Bio-Rad Laboratories Inc. (BIO) Tops Q2 EPS by 14c
Tweet
Share
E-mailGet Alerts BIO Hot Sheet
Price: $281.11 -0.47%
Revenue Growth %: -4.3%
Financial Fact:
Net income per share basic attributable to Bio-Rad: 0.61
Today's EPS Names:
OCCI, MAYS, CRMT, More
Revenue Growth %: -4.3%
Financial Fact:
Net income per share basic attributable to Bio-Rad: 0.61
Today's EPS Names:
OCCI, MAYS, CRMT, More
Join SI Premium – FREE
Bio-Rad Laboratories Inc. (NYSE: BIO) reported Q2 EPS of $1.09, $0.14 better than the analyst estimate of $0.95. Revenue for the quarter came in at $536.8 million versus the consensus estimate of $537.58 million.
For earnings history and earnings-related data on Bio-Rad Laboratories Inc. (BIO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Hermès can regain momentum despite China weakness, Jefferies says
- Credo Technology pops 3.5% as Evercore initiates with monster $325 price target
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
